Literature DB >> 24614592

Optimizing current treatment of gout.

Frances Rees1, Michelle Hui1, Michael Doherty1.   

Abstract

Gout is the most common inflammatory arthritis worldwide. Although effective treatments exist to eliminate sodium urate crystals and to 'cure' the disease, the management of gout is often suboptimal. This article reviews available treatments, recommended best practice and barriers to effective care, and how these barriers might be overcome. To optimize the management of gout, health professionals need to know not only how to treat acute attacks but also how to up-titrate urate-lowering therapy against a specific target level of serum uric acid that is below the saturation point for crystal formation. Current perspectives are changing towards much earlier use of urate-lowering therapy, even at the time of first diagnosis of gout. Holistic assessment and patient education are essential to address patient-specific risk factors and ensuring adherence to individualized therapy. Shared decision-making between a fully informed patient and practitioner greatly increases the likelihood of curing gout.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24614592     DOI: 10.1038/nrrheum.2014.32

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  123 in total

1.  Acute gout management during hospitalization: a need for a protocol.

Authors:  S R Gnanenthiran; G M Hassett; K A Gibson; H P McNeil
Journal:  Intern Med J       Date:  2010-01-04       Impact factor: 2.048

2.  Treatment of gout with allopurinol and sulphinpyrazone in combination and with allopurinol alone.

Authors:  W C Kuzell; L M Seebach; R P Glover; A E Jackman
Journal:  Ann Rheum Dis       Date:  1966-11       Impact factor: 19.103

3.  Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability.

Authors:  Nicola Dalbeth; Keith J Petrie; Meaghan House; Jimmy Chong; Wingchi Leung; Rini Chegudi; Anne Horne; Greg Gamble; Fiona M McQueen; William J Taylor
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

4.  Ketoprofen versus indomethacin in patients with acute gouty arthritis: a multicenter, double blind comparative study.

Authors:  R D Altman; S Honig; J M Levin; R W Lightfoot
Journal:  J Rheumatol       Date:  1988-09       Impact factor: 4.666

Review 5.  Hyperuricemia and incident hypertension: a systematic review and meta-analysis.

Authors:  Peter C Grayson; Seo Young Kim; Michael LaValley; Hyon K Choi
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-01       Impact factor: 4.794

6.  Gout epidemiology: results from the UK General Practice Research Database, 1990-1999.

Authors:  T R Mikuls; J T Farrar; W B Bilker; S Fernandes; H R Schumacher; K G Saag
Journal:  Ann Rheum Dis       Date:  2005-02       Impact factor: 19.103

7.  Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial.

Authors:  Hein J E M Janssens; Matthijs Janssen; Eloy H van de Lisdonk; Piet L C M van Riel; Chris van Weel
Journal:  Lancet       Date:  2008-05-31       Impact factor: 79.321

8.  Intermittent control of hyperuricemia in the treatment of gout.

Authors:  P W Bull; J T Scott
Journal:  J Rheumatol       Date:  1989-09       Impact factor: 4.666

9.  Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study.

Authors:  Naomi Schlesinger; Marc De Meulemeester; Andrey Pikhlak; A Eftal Yücel; Dominik Richard; Valda Murphy; Udayasankar Arulmani; Peter Sallstig; Alexander So
Journal:  Arthritis Res Ther       Date:  2011-03-25       Impact factor: 5.156

10.  Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study.

Authors:  Hyon K Choi; Lucia Cea Soriano; Yuqing Zhang; Luis A García Rodríguez
Journal:  BMJ       Date:  2012-01-12
View more
  47 in total

Review 1.  Febuxostat: a review of its use in the treatment of hyperuricaemia in patients with gout.

Authors:  James E Frampton
Journal:  Drugs       Date:  2015-03       Impact factor: 9.546

Review 2.  Coexistent digital gouty and infective flexor tenosynovitis.

Authors:  Qasim Akram; Michael Hughes; Lindsay Muir
Journal:  BMJ Case Rep       Date:  2016-06-29

3.  American Society of Nephrology quiz and questionnaire 2014: acid-base and electrolyte disorders.

Authors:  Mitchell H Rosner; Mark A Perazella; Michael J Choi
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-23       Impact factor: 8.237

Review 4.  [Full version of the S2e guidelines on gouty arthritis : Evidence-based guidelines of the German Society of Rheumatology (DGRh)].

Authors:  U Kiltz; R Alten; M Fleck; K Krüger; B Manger; U Müller-Ladner; H Nüßlein; M Reuss-Borst; A Schwarting; H Schulze-Koops; A Tausche; J Braun
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

5.  Poorly controlled gout: who is doing poorly?

Authors:  Faith Li-Ann Chia
Journal:  Singapore Med J       Date:  2016-08       Impact factor: 1.858

6.  IL-33 enhances macrophage release of IL-1β and promotes pain and inflammation in gouty arthritis.

Authors:  Victor Fattori; Larissa Staurengo-Ferrari; Tiago H Zaninelli; Rubia Casagrande; Rene D Oliveira; Paulo Louzada-Junior; Thiago M Cunha; Jose C Alves-Filho; Mauro M Teixeira; Fernando Q Cunha; Flavio A Amaral; Waldiceu A Verri
Journal:  Inflamm Res       Date:  2020-09-04       Impact factor: 4.575

7.  Gout and sickle cell disease: not all pain is sickle cell pain.

Authors:  Sarthak Gupta; Jennifer C Yui; Dihua Xu; Courtney D Fitzhugh; Caroline Clark; Salahuddin Siddiqui; Anna K Conrey; Gregory J Kato; Caterina P Minniti
Journal:  Br J Haematol       Date:  2015-04-20       Impact factor: 6.998

8.  Key barriers to gout care: a systematic review and thematic synthesis of qualitative studies.

Authors:  Sharan K Rai; Hyon K Choi; Sally H J Choi; Anne F Townsend; Kam Shojania; Mary A De Vera
Journal:  Rheumatology (Oxford)       Date:  2018-07-01       Impact factor: 7.580

9.  Eucalyptol alleviates inflammation and pain responses in a mouse model of gout arthritis.

Authors:  Chengyu Yin; Boyu Liu; Ping Wang; Xiaojie Li; Yuanyuan Li; Xiaoli Zheng; Yan Tai; Chuan Wang; Boyi Liu
Journal:  Br J Pharmacol       Date:  2020-02-12       Impact factor: 8.739

10.  Association of Chronic Kidney Disease With Allopurinol Use in Gout Treatment.

Authors:  Ana Beatriz Vargas-Santos; Christine E Peloquin; Yuqing Zhang; Tuhina Neogi
Journal:  JAMA Intern Med       Date:  2018-11-01       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.